SBS Code stringlengths 9 11 | SBS Code (Hyphenated) stringlengths 11 12 | Short Description stringlengths 3 74 | Long Description stringlengths 7 544 | Chapter float64 1 25 ⌀ | Chapter Name stringclasses 25
values | Block int64 1 4.02k | Block Name stringlengths 3 99 ⌀ | Definition stringlengths 11 1.18k ⌀ | Includes stringlengths 4 1.31k ⌀ | Excludes stringlengths 1 1.23k ⌀ | Guidelines stringlengths 1 1.54k ⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|
731000170 | 73100-01-70 | Reticulated platelets | Measurement of Reticulated Platelets | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Assay for determining percentage of reticulated platelets | null | null | null |
731000180 | 73100-01-80 | Interpretationperipheral blood smear | Physician Interpretation of peripheral blood smear with written report | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Physician review, interpertation, and examination report of peripheral blood smear | null | null | null |
731000190 | 73100-01-90 | Interpretationbone marrow smear | Interpretation of Bone Marrow smear | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Physician interpertation of bone marrow smear | null | null | null |
731000200 | 73100-02-00 | Chromogenic | Chromogenic substrate assay | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of blood thinner concentration (e.g. Heparin, fondaparinux) | null | null | null |
731000210 | 73100-02-10 | Clot retraction | Clot retraction test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of amount of serum and red blood cells in a blood clot | null | null | null |
731000220 | 73100-02-20 | Diluted Whole Blood Clotting test (dWBCT) | Clot lysis time of whole blood dilution | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of clot break down time | null | null | null |
731000230 | 73100-02-30 | Clotting factor II (Prothrombin) | Measurement of clotting factor II (Prothrombin) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor II (Prothrombin) presence (e.g. Liver diseases, Vitamin K deficency, anticoagulation therapy evaluation, prolonged prothrombin time) | null | null | null |
731000240 | 73100-02-40 | Clotting factor V (Proaccelerin) | Measurement of clotting factor V [Proaccelerin, labile factor, accelerator globulin (AcG)] | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor V (Proaccelerin) presence (e.g. liver disease, myeloproliferative disorders) | null | null | null |
731000250 | 73100-02-50 | Clotting factor VII (Proconvertin) | Measurement of clotting factor VII (Proconvertin, stable factor) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor VII (Proconvertin) presence (e.g. Liver diseases, Vitamin K deficency, anticoagulation therapy evaluation, prolonged prothrombin time) | null | null | null |
731000260 | 73100-02-60 | Clotting factor VIII (AHG) | Measurement of clotting factor VIII (AHG), 1-stage | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor VIII (AHG) presence (e.g. hemophilia A, CF VII Deficency, Willebrand disease) | null | null | null |
731000270 | 73100-02-70 | Clotting factor VIII Ag | Measurement of clotting factor VIII related antigens (VIII;Ag) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor VIII (AHG) related antigen presence in patient serum | null | null | null |
731000280 | 73100-02-80 | VWF-R Co factor | Measurement of clotting factor VIII [von willebrand factor (vWF)] activity, ristocetin cofactor test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Assay for coagulation factor (VIII/von Willebrand factor) via ristocetin to measure platelet aggregation (e.g. to diagnose hemophilia A or von Willebrand’s disease ) | null | null | null |
731000290 | 73100-02-90 | VWF antigen | Measurement of clotting factor VIII [von Willebrand factor (vWF)] antigen | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of coagulation factor (VIII/von Willebrand factor) Antigens (e.g. to diagnose von Willebrand disease and its types) | null | null | null |
731000300 | 73100-03-00 | VWF-Multimetric | Measurement of clotting factor VIII [von Willebrand factor (vWF)] with Multimeric analysis | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Multimetric analysis for coagulation factor (VIII/von Willebrand factor) to evaluate VWF subtypes | null | null | null |
731000310 | 73100-03-10 | Clotting factor IX (PTC) | Measurement of clotting factor IX (PTC; Christmas) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor IX presence (e.g. hemophilia B, Christmas disease) | null | null | null |
731000320 | 73100-03-20 | Clotting factor X | Measurement of clotting factor X (Stuart-Prower) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor X presence (e.g. liver disease or vitamin K deficiency) | null | null | null |
731000330 | 73100-03-30 | Clotting factor XI (PTA) | Measurement of clotting factor XI (plasma thromboplastin antecendent (PTA)) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor XI presence (e.g. hemophilia C) | null | null | null |
731000340 | 73100-03-40 | Clotting factor XII | Measurement of clotting factor XII (Hageman) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor XII (Hageman) presence | null | null | null |
731000350 | 73100-03-50 | Clotting factor XIII | Measurement of clotting factor XIII (fibrin stabilizing) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of coagulation Factor XIII presence (e.g. bleeding disorders with normal PT;PTT) | null | null | null |
731000360 | 73100-03-60 | Clotting factor XIII Solubility Screen | Solubility screening for clotting factor XIII (fibrin stabilizing) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Solubility screening test for determination of coagulation Factor XIII presence | null | null | null |
731000370 | 73100-03-70 | Fletcher factor | Measurement of Fletcher factor (Plasma Prekallikrein) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Clotting assay for presence of fletcher factor (plasma prekallikrein) | null | null | null |
731000380 | 73100-03-80 | Fitzgerald factor | Measurement of high molecular weight kininogen (Fitzgerald factor assay) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Clotting assay for presence of fitzgerald factor | null | null | null |
731000390 | 73100-03-90 | Antithrombin III activity | Measurement of anticoagulant (Antithrombin III) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of clotting inhibitor Antithrombin III activity [e.g.deep vein thrombosis (DVT), pulmonary embolism (PE)]. | null | null | null |
731000400 | 73100-04-00 | Antithrombin III antigen | Measurement of anticoagulant (Antithrombin III) antigens | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of clotting inhibitor Antithrombin III antigens [e.g.deep vein thrombosis (DVT), pulmonary embolism (PE)]. | null | null | null |
731000410 | 73100-04-10 | Protein C antigen | Measurement of anticoagulant (Protein C) antigens | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of clotting inhibitor Protein C antigens (e.g. congenital or acquired protein C deficiency) | null | null | null |
731000420 | 73100-04-20 | Protein C activity | Measurement of anticoagulant (Protein C) Activity | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of clotting inhibitor Protein C activity (e.g. congenital or acquired protein C deficiency) | null | null | null |
731000430 | 73100-04-30 | Total protein S | Measurement of anticoagulant (Total Protein S) Levels | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of clotting inhibitor total Protein S levels (e.g. congenital or acquired protein S deficiency) | null | null | null |
731000440 | 73100-04-40 | Free protein S | Measurement of anticoagulant (Free Protein S) Levels | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of clotting inhibitor free Protein S levels (e.g. congenital or acquired protein S deficiency) | null | null | null |
731000450 | 73100-04-50 | APC resistance | Measurement of Activated Protein C (APC) resistance | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Active Protein C resistance (e.g. venous thromboembolism, arterial thrombosis, recurrent miscarriage) | null | null | null |
731000460 | 73100-04-60 | Factor inhibitor | Factor inhibitor assay | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Quantification of coagulation factor inhibitor after positive screen results for any of the other coagulation factors. | null | null | null |
731000470 | 73100-04-70 | Thrombomodulin levels | Measurement of thrombomodulin (TM; endothelial cofactor) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Thrombomodulin plasma levels (e.g. SLE, cancers, disseminated intravascular coagulation, pulmonary thromboembolism, kidney damage, thrombotic thrombocytopenic purpura). | null | null | null |
731000480 | 73100-04-80 | LW clotting time | Lee and White clotting time test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Clot formation time by Lee and White method (e.g. monitoring of anticoagulant therapy effect) | null | null | null |
731000490 | 73100-04-90 | ACT test | Activated clotting time (ACT) test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Clot formation time by physical activation method (e.g. monitoring of anticoagulant therapy effect) | null | null | null |
731000500 | 73100-05-00 | Other clotting time test | Other clotting time test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Clot formation time by other specified methods | null | null | null |
731000510 | 73100-05-10 | Euglobulin lysis time | Euglobulin Lysis time Test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of euglobulin clot breakdown time by other specified methods (e.g. fibrinolytic activity) | null | null | null |
731000520 | 73100-05-20 | FDP test; SemiQuantitative | SemiQuantitative analysis of fibrin degradation/split products (FDP; FSP) using agglutination slide method | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of fibrinogen break down products via slide agglutination method (e.g. disseminated intravascular coagulation) | null | null | null |
731000530 | 73100-05-30 | Paracoagulation FDP test | Paracoagulation test for fibrin degradation/split products (FDP; FSP) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of fibrinogen break down products via paracoagulation test (e.g. disseminated intravascular coagulation) | null | null | null |
731000540 | 73100-05-40 | FDP test; Quant. | Quantitative test for fibrin degradation/split products (FDP; FSP) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Quantatative evaluation of fibrinogen break down products | null | null | null |
731000550 | 73100-05-50 | D-Dimer (Qual/semiQuant) | Qualitative or SemiQuantitative analysis of D-dimer Fibrin degradation products | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of D-dimer presence via qualitative or semiquantitative methods (e.g. immunochromatography) | null | null | null |
731000560 | 73100-05-60 | D-Dimer; Quant. | Quantitative analysis of D-dimer fibrin degradation products | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of D-dimer presence via quantitative methods (e.g. latex immunoassay) | null | null | null |
731000570 | 73100-05-70 | D-Dimer (Ultrasensitive) | Ultrasensitive (Qualitative or SemiQuantitative) analysis of D-dimer fibrin degradation products | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of D-dimer presence via ultrasensitive, qualitative or semiquantitative methods (e.g. ELFA; for venous thromboembolism) | null | null | null |
731000580 | 73100-05-80 | Fibrinogen activity | Measurement of fibrinogen activity | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of Fibrinogen Clotting Activity (e.g. abnormal bleeding or clotting) | null | null | null |
731000590 | 73100-05-90 | Fibrinogen antigen s | Measurement of fibrinogen antigens | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Fibrinogen Antigen presence | null | null | null |
731000600 | 73100-06-00 | Screening for coagulopathy report | Interpretation and report for coagulopathy screening | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Physician or non physician interpertation and report for range of tests performed for coagulaopathy screening | null | null | null |
731000610 | 73100-06-10 | Whole Blood Coagulation/Fibrinolysis w/ inter & report | Coagulation or fibrinolysis (clot break down) function measurement with interpretation and written report | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Physician interpertation of whole blood coagulation/fibrinolysis profile | null | null | Assign this code per day of service |
731000620 | 73100-06-20 | Functional assay Coagulation/Fibrinolysis NEC | Functional assay for coagulation/fibrinolysis unspecified chemical compound | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Functional activity test for unspecified biochemical compound related to coagulation/fibrinolysis (e.g. ADAMTS-13, other analytes) | null | null | Assign this code for each compound |
731000630 | 73100-06-30 | Fibrinolytic Plasmin | Measurement of plasmin fibrinolytic factor | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Plasmin activity | null | null | null |
731000640 | 73100-06-40 | Fibrinolytic Alpha-2 Antiplasmin | Measurement of Alpha-2 Antiplasmin Fibrinolytic factor | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of alpha-2 antiplasmin levels | null | null | null |
731000650 | 73100-06-50 | Fibrinolytic Plasminogen Activator | Measurement of Plasminogen Activator Fibrinolytic factor | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of plasminogen activator activity | null | null | null |
731000660 | 73100-06-60 | Fibrinolytic Plasminogen Excluding antigen ic | Measurement of Plasminogen Fibrinolytic factor (excluding antigenic assays) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of direct plasminogen levels (e.g. thrombosis, ligneous conjunctivitis) | null | null | null |
731000670 | 73100-06-70 | Fibrinolytic Plasminogen antigen ic | Measurement of Plasminogen Fibrinolytic factor (including antigenic assay) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of antigenic (i.e. measuring antibody concentration) plasminogen activity (e.g. thrombosis, ligneous conjunctivitis) | null | null | null |
731000680 | 73100-06-80 | Heinz Bodies (Direct) | Direct measurement of Heinz bodies | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Heinz bodies presence (e.g. hemolytic anemias, G6PD deficiency, alpha thalassemia, unstable hemoglobin, ingestion of certain drugs). | null | null | null |
731000690 | 73100-06-90 | Heinz bodies (Induced) by admin Acetyl phenylhydrazine | Induced measurement of Heinz bodies by administration of Acetyl phenylhydrazine | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Induced Measurement of Heinz bodies (e.g. unstable hemoglobins). | null | null | null |
731000700 | 73100-07-00 | Kleihauer's Betke test-Fetal | Assessment of fetal-maternal haemorrhage by differential lysis method | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Test for quantification of fetal RBC or hemoglobin (Rh+) mixing with maternal circulation (Rh-) | null | null | null |
731000710 | 73100-07-10 | Rosette test-Fetal | Assessment of fetal-maternal haemorrhage using the rosette method | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Test to determine wether fetal blood (Rh+) mixed with maternal maternal blood (Rh-) | null | null | null |
731000720 | 73100-07-20 | Hemolysin Acid | Analysis of blood specimen mixed with acid for hemolysis evaluation | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of red blood cells breakdown | null | null | null |
731000730 | 73100-07-30 | Heparin Concentration | Measurement of Heparin Concentration | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Assay for measuring amount of heparin | null | null | null |
731000740 | 73100-07-40 | Heparin Neutralization | Neutralization of Heparin | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Assay for neutralizing heparin (e.g. suspected heparin contamination, removal from heparinized lines samples as in neonates). | null | null | null |
731000750 | 73100-07-50 | Heparin-Protamine Tolerance test | Assay for Heparin-protamine tolerance | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Assay for heparin activity | null | null | null |
731000760 | 73100-07-60 | Iron Stain | Iron stain on peripheral blood smear sample | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Peripheral blood stain treated with iron stain to visulize red bloos cells siderotic granules (e.g. for impaired hemoglobin production, e.g. sickle cell) | null | null | null |
731000770 | 73100-07-70 | LAP test | Assay for Leukocyte Alkaline Phosphatase with count | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of leukocyte Alkaline phosphate levels with white blood cell count (e.g. leukemoid reaction or chronic granulocytic leukemia) | null | null | null |
731000780 | 73100-07-80 | RBC Mechanical Fragility | Measurement of RBC hemolysis susceptibility due to mechanical stress | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Measurement of RBC survival ability when subjected to mechanical stress | null | null | null |
731000790 | 73100-07-90 | Muramidase | Measurement of enzyme Muramidase levels | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of plasma Muramidase levels (e.g. for diagnosis of leukemias) | null | null | null |
731000800 | 73100-08-00 | Osmotic Fragility test (Unincubated) | Measurement of RBC hemolysis susceptibility due to osmotic stress; Unincubated | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Measurement of RBC survival ability when subjected to osmotic stress (e.g. spherocytosis, thalassemia) | null | null | null |
731000810 | 73100-08-10 | Osmotic Fragility test (Incubated) | Measurement of RBC hemolysis susceptibility due to osmotic stress; Incubated | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Measurement of RBC survival ability when subjected to osmotic stress; incubated in sodium chloride solution (e.g. spherocytosis, thalassemia) | null | null | null |
731000820 | 73100-08-20 | Platelet Aggregation test | In vitro platelet aggregation Assay; each chemical reagent | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of platetelt aggregation after additon of a certain chemical reagent to the specimen (e.g. low platelet count, bleeding disorders). | null | null | When different reagents are used, assign this code more than once |
731000830 | 73100-08-30 | Phospholipid Clotting time | Measurement of clotting time with addition of platelet phospholipid reagent | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Clotting time after addition of phospholipid reagent (e.g. detection of antiphospholipid antibodies ) | null | null | null |
731000840 | 73100-08-40 | Hexagonal Phase Phospholipid | Measurement of clotting time with addition of hexagonal phospholipid reagent | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Coagulation time after addition of hexagonal phospholipid reagent (e.g. detection of antiphospholipid antibodies ) | null | null | null |
731000850 | 73100-08-50 | Prothrombin time test | Measurement of Prothrombin clotting time | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of prothrombin time in plasma | INTERNatIonAL NorMALIZED RatIO ( INR ) | null | null |
731000860 | 73100-08-60 | Plasma Fractions Clotting time | Measurement of clotting time with addition of plasma fractions | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Clotting time after addition of plasma fractions (e.g. Prolonged PT time ) | null | null | Assign this code for each plasma fraction |
731000870 | 73100-08-70 | RVVT | Russell viper venom time (RVVT) test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Clotting test of RVVT (e.g. screening for Lupus anticoagulants) | null | null | null |
731000880 | 73100-08-80 | DRVVT | Dilute Russell viper venom time (DRVVT) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Clotting test of dRVVT (e.g. screening for Lupus anticoagulants) | null | null | null |
731000890 | 73100-08-90 | Reptilase time (RT) | Plasma reptilase time (RT) clotting assay | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Evaluation of reptilase (venom extract enzyme) Impact on clotting time | null | null | null |
731000900 | 73100-09-00 | ESR (Manual) | Manual Measurement of Erythrocyte Sedimentation Rate | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Manual Determination of Erythrocyte sedimentation rate (e.g. to determine presence of inflammation) | SEDIMENTatIon RatE, ERYTHROCYTE; Non-AUtoMatED | null | null |
731000910 | 73100-09-10 | ESR (Automated) | Automated Measurement of Erythrocyte Sedimentation Rate | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Automated Determination of Erythrocyte sedimentation rate (e.g. to determine presence of inflammation) | null | null | null |
731000920 | 73100-09-20 | TT (Thrombin time) | Measurement of clotting time by thrombin reagent | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Clotting time after addition of thrombin reagent (e.g. for presence of heparin or similar anticoagulants) | null | null | null |
731000930 | 73100-09-30 | Thrombin time; titer | Measurement of clotting time using different thrombin reagent concentrations | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of Clotting time after addition of varying concentrations of thrombin reagent (e.g. for presence of heparin or similar anticoagulants) | null | null | null |
731000940 | 73100-09-40 | TTI test | Tissue Thrombin Inhibition (TTI) Test | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | TTI test for detection of lupus anticoagulants | null | null | null |
731000950 | 73100-09-50 | PTT (Partial Thromboplastin time) | Measurement of partial thromboplastin time (PTT) from plasma or whole blood | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of PTT using plasma/whole blood (e.g. bleeding disorders; monitoring anticoagulant therapy) | null | null | null |
731000960 | 73100-09-60 | PTT; Plasma Fractions | Measurement of partial thromboplastin time (PTT) by plasma fractions | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of PTT after addition of plasma fractions (e.g. bleeding disorders; monitoring anticoagulant therapy) | null | null | null |
731000970 | 73100-09-70 | Viscosity test | Measurement of Serum Viscosity Levels | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Viscosity test (e.g. hyperviscosity syndrome) | null | null | null |
731000980 | 73100-09-80 | Unlist hematology proc | Unlisted Hematology Procedure | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Unlisted Hematology procedure | null | null | null |
731000990 | 73100-09-90 | Febrile Agglutinin test | Measurement of antibody to infectious organism. (e.g. Brucella, Francisella, Murine typhus, Q fever, Rocky Mountain spotted fever) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Measurement of febrile agglutinins for infection detection (Widal’s test) | null | null | Assign this code for each tested antigen |
731001000 | 73100-10-00 | Allergen Specific IgG; Quant./Qual. | Quantitative/Semiquantitative measurement of antibody (IgG) to allergic substance | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Detection of allegren specific IgG in serum (e.g. food allergy, drug allergy, or environmental allergy) | null | null | Assign this code for each tested allergen |
731001010 | 73100-10-10 | Allergen Specific IgE; Quant./Qual. | Quantitative/Semiquantitative measurement of antibody (IgE) to allergic substance | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Detection of allegren specific IgE in serum (e.g. food allergy, drug allergy, or environmental allergy) | null | null | Assign this code for each crude allergen extract |
731001020 | 73100-10-20 | Qual. Allergen Specific IgE | Qualitative measurement of antibody (IgE) to allergic substance; Multiallergen Screen | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Detection of allegren specific IgE in serum by multiallergen screening tool (e.g. determination of allergen) (e.g. multiple radioallergosorbent tests(MAST)) | null | null | null |
731001030 | 73100-10-30 | Allergen Specific IgE (recombinant/purified); Quant./Qual. | Quantitative/Semiquantitative measurement of antibody (IgE) to allergic substance using recombinant/purified components | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Detection of allegren specific IgE in serum by recombinant or purified components (e.g. determination of allergen) | null | null | null |
731001040 | 73100-10-40 | WBC (Leukocyte) Ab identification | Assay for white blood cells (Identification) antibodies (Identification) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Leukocyte antibody identification (e.g. infertility, transfusion reactions). | null | null | null |
731001050 | 73100-10-50 | Platelet Ab identification | Assay for platelets antibodies (Identification) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Platelet antibody identification (e.g. bruising, excessive bleeding, or a low platelet count). | null | null | null |
731001060 | 73100-10-60 | Platelet-Ig Ab identification | Assay for platelets associated immunoglobulins antibodies (Identification) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Pletelet associated immunoglobulins antibody identification (e.g. bruising, excessive bleeding, or a low platelet count). | null | null | null |
731001070 | 73100-10-70 | ANA | Measurement of antinuclear antibodies (ANA) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of ANA presence in serum (e.g suspecting autoimmune disorders) | ANTI LA (SSB)
ANTI RO (SSA) | null | Assign this code when results are reported qualitatively (positive/negative) |
731001080 | 73100-10-80 | ANA (Titer) | Measurement of antinuclear antibodies titer (ANA) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of ANA presence in serum titer (e.g suspecting autoimmune disorders) | null | null | Assign this code when results are reported as a ratio (e.g.1:320) |
731001090 | 73100-10-90 | ASO (Titer) | Measurement of Antistreptolysin O (ASO) with titer dilution | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of ASO presence in blood with titer (e.g. for streptococcus infection) | null | null | null |
731001100 | 73100-11-00 | ASO | Measurement of Antistreptolysin O (ASO) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of ASO presence in blood (e.g. for bacterial endocarditis, glomerulonephritis, rheumatic fever, scarlet fever, strep throat) | null | null | Assign this code when results are reported qualitatively (positive/negative) |
731001110 | 73100-11-10 | Cross Match | Crossmatch with physician interpretation and report due to difficult cross matching | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Laboratory perform Crossmatching of a specimen due to crossmatch difficulty from irregular antibodies or others; requiring blood bank physician interpretation and report | null | null | null |
731001120 | 73100-11-20 | Transfusion Reaction | Transfusion Reaction investigation with blood bank physician interpretation and report | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Transfusion reaction requiring blood bank physician interpretation and report | null | null | null |
731001130 | 73100-11-30 | BB Physician Authorization report | Blood Bank physician authorization for service deviation | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | The blood bank physician authorize the deviation from standard procedures for certain cases such as in the use of outdated blood or transfusion of Rh incompatible units | null | null | null |
731001140 | 73100-11-40 | CRP | Measurement of C Reactive Protein | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of C-reactive protein presence (eg. inflammatory diseases like rheumatoid arthritis) | null | null | null |
731001150 | 73100-11-50 | CRP H.S | Measurement of High sensitive C-reactive Protein (hs-CRP) | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | Determination of high sensitivity C-reactive protein presence (eg. inflammatory diseases like cardiovascular inflammatory conditions.) | null | null | null |
731001160 | 73100-11-60 | Beta 2 GlycoProtein I Ab | Assay for beta 2 glycoProtein antibodies | 21 | Laboratory and Pathology | 3,100 | Study of Blood Products & Antibodies | B2GP1 antibody identification (e.g. clotting) | BETA -2- GLYCOPROTEIN 1 ABS (IGM) | null | Assign this code for each tested antibody |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.